Search Results - "Carriero, M V"

Refine Results
  1. 1

    TGF-β1 exposure induces epithelial to mesenchymal transition both in CSCs and non-CSCs of the A549 cell line, leading to an increase of migration ability in the CD133+ A549 cell fraction by Tirino, V, Camerlingo, R, Bifulco, K, Irollo, E, Montella, R, Paino, F, Sessa, G, Carriero, M V, Normanno, N, Rocco, G, Pirozzi, G

    Published in Cell death & disease (02-05-2013)
    “…Metastasis is the leading cause of death by cancer. Non-small-cell lung cancer (NSCLC) represents nearly 85% of primary malignant lung tumours. Recent…”
    Get full text
    Journal Article
  2. 2

    Tumor clearance of technetium 99m-sestamibi as a predictor of response to neoadjuvant chemotherapy for locally advanced breast cancer by Ciarmiello, A, Del Vecchio, S, Silvestro, P, Potena, M I, Carriero, M V, Thomas, R, Botti, G, D'Aiuto, G, Salvatore, M

    Published in Journal of clinical oncology (01-05-1998)
    “…Since we have previously shown that the efflux rate of technetium 99m (99mTc) sestamibi, a transport substrate of P-glycoprotein (Pgp), is directly correlated…”
    Get more information
    Journal Article
  3. 3

    Coordinate up-regulation of Sp1 DNA-binding activity and urokinase receptor expression in breast carcinoma by ZANNETTI, A, DEL VECCHIO, S, CARRIERO, M. V, FONTI, R, FRANCO, P, BOTTI, G, D'AIUTO, G, STOPPELLI, M. P, SALVATORE, M

    Published in Cancer research (Chicago, Ill.) (15-03-2000)
    “…The regulatory mechanisms underlying the overexpression of urokinase-type plasminogen activator (uPA) and its receptor (uPAR) in highly invasive breast…”
    Get full text
    Journal Article
  4. 4

    Early vitronectin receptor downregulation in a melanoma cell line during all-trans retinoic acid-induced apoptosis by Baroni, A., Paoletti, I., Silvestri, I., Buommino, E., Carriero, M.V.

    Published in British journal of dermatology (1951) (01-03-2003)
    “…Summary Background Recent evidence assigns the vitronectin receptors (VnRs) an important role in regulating tumour cell invasion and dissemination. In vivo and…”
    Get full text
    Journal Article
  5. 5

    In vivo detection of multidrug-resistant (MDR1) phenotype by technetium-99m sestamibi scan in untreated breast cancer patients by Vecchio, S D, Ciarmiello, A, Potena, M I, Carriero, M V, Mainolfi, C, Botti, G, Thomas, R, Cerra, M, D'Aiuto, G, Tsuruo, T, Salvatore, M

    Published in European Journal of Nuclear Medicine (01-02-1997)
    “…Technetium-99m sestamibi is a transport substrate recognised by the multidrug-resistant P-glycoprotein (Pgp). To test whether 99mTc-sestamibi efflux is…”
    Get full text
    Journal Article
  6. 6

    Fractional Retention of Technetium-99m-Sestamibi as an Index of P-Glycoprotein Expression in Untreated Breast Cancer Patients by Del Vecchio, Silvana, Ciarmiello, Andrea, Pace, Leonardo, Potena, Maria I, Carriero, Maria V, Mainolfi, Ciro, Thomas, Renato, D'Aiuto, Giuseppe, Tsuruo, Takashi, Salvatore, Marco

    Published in The Journal of nuclear medicine (1978) (01-09-1997)
    “…The multidrug-resistant phenotype is characterized by the reduced intracellular retention of several structurally and functionally unrelated cytotoxic…”
    Get full text
    Journal Article
  7. 7

    Vitronectin binding to urokinase receptor in human breast cancer by Carriero, M V, Del Vecchio, S, Franco, P, Potena, M I, Chiaradonna, F, Botti, G, Stoppelli, M P, Salvatore, M

    Published in Clinical cancer research (01-08-1997)
    “…Functional assembly of the plasminogen-dependent proteolytic system on the cell surface requires multiple interactions involving urokinase (uPA), urokinase…”
    Get full text
    Journal Article
  8. 8

    Human urokinase receptor concentration in malignant and benign breast tumors by in vitro quantitative autoradiography : comparison with urokinase levels by DEL VECCHIO, S, STOPPELLI, M. P, SALVATORE, M, CARRIERO, M. V, FONTI, R, MASSA, O, PEI YONG LI, BOTTI, G, CERRA, M, D'AIUTO, G, ESPOSITO, G

    Published in Cancer research (Chicago, Ill.) (01-07-1993)
    “…We measured the tissue concentration of human urokinase receptor (uPAR) in 22 breast carcinomas and 9 benign breast lesions using in vitro quantitative…”
    Get full text
    Journal Article
  9. 9

    The Cleavage of the Urokinase Receptor Regulates Its Multiple Functions by Montuori, Nunzia, Carriero, Maria Vincenza, Salzano, Salvatore, Rossi, Guido, Ragno, Pia

    Published in The Journal of biological chemistry (06-12-2002)
    “…The urokinase-type plasminogen activator (uPA) is able to cleave its cell surface receptor (uPAR) anchored to the cell membrane through a…”
    Get full text
    Journal Article
  10. 10

    Tissue distribution of soluble and receptor-bound urokinase in human breast cancer using a panel of monoclonal antibodies by CARRIERO, M. V, FRANCO, P, DEL VECCHIO, S, MASSA, O, BOTTI, G, D'AIUTO, G, STOPPELLI, M. P, SALVATORE, M

    Published in Cancer research (Chicago, Ill.) (15-10-1994)
    “…Current evidence regarding the regulation of urokinase-dependent extracellular proteolysis indicates that plasminogen activation is a surface-associated…”
    Get full text
    Journal Article
  11. 11

    Local Concentration of Folate Binding Protein GP38 in Sections of Human Ovarian Carcinoma by In Vitro Quantitative Autoradiography by Li, Pei Yong, Del Vecchio, Silvana, Fonti, Rosa, Carriero, Maria V, Potena, Maria I, Botti, Gerardo, Miotti, Silvia, Lastoria, Secondo, Menard, Sylvie, Colnaghi, Maria I, Salvatore, Marco

    Published in The Journal of nuclear medicine (1978) (01-04-1996)
    “…Folate binding protein (FBP) GP38 is a membrane-associated glycoprotein that mediates the intracellular transport of folates. The enhanced expression of FBP in…”
    Get full text
    Journal Article
  12. 12

    The soluble form of urokinase receptor promotes angiogenesis through its Ser88‐Arg‐Ser‐Arg‐Tyr92 chemotactic sequence by BIFULCO, K., LONGANESI‐CATTANI, I., GALA, M., DI CARLUCCIO, G., MASUCCI, M. T., PAVONE, V., LISTA, L., ARRA, C., STOPPELLI, M. P., CARRIERO, M. V.

    Published in Journal of thrombosis and haemostasis (01-12-2010)
    “…Background: The urokinase plasminogen activator receptor (u‐PAR) focuses the proteolytic activity of the urokinase plasminogen activator (u‐PA) on the…”
    Get full text
    Journal Article
  13. 13

    Distribution of ferritin, transferrin and lactoferrin in breast carcinoma tissue by Rossiello, R, Carriero, M V, Giordano, G G

    Published in Journal of clinical pathology (01-01-1984)
    “…An immunoperoxidase staining technique was used for detecting three major iron binding proteins (ferritin, transferrin and lactoferrin) in 40 breast carcinoma…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Urokinase receptor-dependent and -independent p56/59(hck) activation state is a molecular switch between myelomonocytic cell motility and adherence by Chiaradonna, F, Fontana, L, Iavarone, C, Carriero, M V, Scholz, G, Barone, M V, Stoppelli, M P

    Published in The EMBO journal (01-06-1999)
    “…Anchorage-independent myelomonocytic cells acquire adherence within minutes of differentiation stimuli, such as the proteolytically inactive N-terminal…”
    Get full text
    Journal Article
  16. 16

    In vitro receptor imaging for characterization of human solid tumors by Del Vecchio, S, Stoppelli, M P, Carriero, M V, Fonti, R, Massa, O, Li, P Y, Botti, G, Cerra, M, D'Aiuto, G, Esposito, G

    Published in Nuclear medicine and biology (01-07-1994)
    “…Since many of the factors involved in tumor growth and progression act through a receptor-mediated mechanism, we applied in vitro receptor imaging techniques…”
    Get more information
    Journal Article
  17. 17

    Ki-67 and B72.3 expression in breast cancer: an immunohistochemical study by Carriero, M V, Bevilacqua, A M, Borrelli, A, Di Bonito, M, Tatangelo, F, Apicella, A

    “…The present study was performed to evaluate Ki-67 and B72.3 immunostaining in 20 selected cases of breast cancer. In particular, we have examined the…”
    Get more information
    Journal Article
  18. 18
  19. 19
  20. 20

    TGF-[beta]1 exposure induces epithelial to mesenchymal transition both in CSCs and non-CSCs of the A549 cell line, leading to an increase of migration ability in the CD133+ A549 cell fraction by Tirino, V, Camerlingo, R, Bifulco, K, Irollo, E, Montella, R, Paino, F, Sessa, G, Carriero, M V, Normanno, N, Rocco, G, Pirozzi, G

    Published in Cell death & disease (01-05-2013)
    “…Metastasis is the leading cause of death by cancer. Non-small-cell lung cancer (NSCLC) represents nearly 85% of primary malignant lung tumours. Recent…”
    Get full text
    Journal Article